microscopic colitis: Inflammation of the colon that is only apparent by microscopic examination.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
189 |
4. Check minimum number of eventsNone |
189 |
5. Include endpointsNone |
189 |
6. Filter based on genotype QC (FinnGen only) |
189 |
Control definitions (FinnGen only)
- Control exclude
- M13_NECROVASC
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M31
Similar endpoints
↥List of similar endpoints to
Microscopic polyangiitis
based on the number of shared cases.
Similar with more cases:
- Other necrotizing vasculopathies (FG)
- Other necrotizing vasculopathies
- Systemic connective tissue disorders
- Autoimmune diseases related-to ILD
- Finngen Rheumatological endpoints
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 813 | 470 | 342 |
| Only index persons | 808 | 467 | 341 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 68.31 | 67.54 | 69.40 |
| Only index persons | 68.35 | 67.57 | 69.42 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 189 | 111 | 78 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.03 |
| Median age at first event (years) | 66.40 | 65.55 | 67.60 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 171
- Matched controls
- 1710
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M31.7
ICD-10 Finland
Microscopic polyangiitis
+∞
164.1
130
*
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
+∞
123.3
103
*
L04AX01
ATC
azathioprine; systemic
98.0
98.6
105
27
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
+∞
75.8
67
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
171.3
71.5
71
7
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
19.8
58.5
100
113
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
42.5
39
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
20.9
39.1
60
43
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
+∞
39.1
36
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
51.8
39.0
46
12
L04AA06
ATC
mycophenolic acid; systemic
71.1
38.5
43
8
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
51.6
36.4
43
11
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
32.3
30
*
H02AB06
ATC
prednisolone; systemic
7.7
30.4
138
600
TK800
NOMESCO Finland
Hemodialysis
54.5
30.0
35
8
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.9
29.9
123
464
N17.9
ICD-10 Finland
Acute renal failure, unspecified
21.0
28.1
42
26
Z49.1
ICD-10 Finland
Extracorporeal dialysis
90.1
27.8
30
*
B03XA02
ATC
darbepoetin alfa; parenteral
53.6
26.6
31
7
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
+∞
25.7
24
*
N18.8
ICD-10 Finland
Other chronic renal failure
21.4
24.4
36
21
A11CC03
ATC
alfacalcidol; systemic
34.0
24.2
31
11
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
63.6
23.8
27
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.6
23.8
126
570
J18.9
ICD-10 Finland
Pneumonia, unspecified
5.7
22.5
81
233
H02AB04
ATC
methylprednisolone; systemic
6.5
22.0
66
150
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
15.4
21.0
35
28
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
9.9
20.5
43
56
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
11.2
20.0
39
44
N085, M318
ICD-10 Finland
NA
+∞
19.1
18
*
C03CA01
ATC
furosemide; systemic
4.6
19.0
93
353
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.0
18.9
59
138
M05BA04
ATC
alendronic acid; oral
7.3
18.3
47
84
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
8.4
18.1
42
64
N18.0
ICD-10 Finland
End-stage renal disease
41.7
18.1
22
6
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.3
17.9
36
43
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
100.0
16.9
18
*
TGC00
NOMESCO Finland
Bronchial lavation
16.8
16.5
26
18
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.0
15.8
47
101
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
9.0
15.3
33
44
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
13.7
15.2
26
22
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.8
15.2
40
73
Z94.0
ICD-10 Finland
Kidney transplant status
87.8
14.8
16
*
ZX120
NOMESCO Finland
Intravenous
6.1
14.8
43
89
ZX108
NOMESCO Finland
Inhalation
39.9
14.8
18
5
L01AA01
ATC
cyclophosphamide; systemic
+∞
13.7
13
*
A02BC02
ATC
pantoprazole; systemic
4.1
13.5
140
901
N08.5*M31.0
ICD-10 Finland
Glomerular disorders in Goodpasture's syndrome
+∞
12.7
12
*
N08.5*M30.0
ICD-10 Finland
Glomerular disorders in polyarteritis nodosa
+∞
12.7
12
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
139.8
12.6
13
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
29.2
12.3
16
6
A12AA04
ATC
calcium carbonate; oral
29.2
12.3
16
6
N19
ICD-10 Finland
Unspecified kidney failure
9.3
12.1
25
31
R50.9
ICD-10 Finland
Fever, unspecified
4.6
12.0
45
123
KA1AE
NOMESCO Finland
Kidney ultrasound examination
15.1
11.8
19
14
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
10.0
11.7
23
26
N08.5*M31.1
ICD-10 Finland
Glomerular disorders in thrombotic thrombocytopenic purpura
+∞
11.6
11
*
WW400
NOMESCO Finland
Plasmaferesis
128.3
11.6
12
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
128.3
11.6
12
*
Z49.0
ICD-10 Finland
Preparatory care for dialysis
27.2
11.3
15
6
127
Kela drug reimbursment
Transplant complication
27.2
11.3
15
6
C08CA01
ATC
amlodipine; oral
3.1
11.0
92
470
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
7.5
11.0
26
40
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
42.8
10.1
12
*
GD1AD
NOMESCO Finland
Thorax CT examination
8.0
9.9
22
31
137
Kela drug reimbursment
Uraemia requiring dialysis
58.4
9.8
11
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
5.5
9.7
29
61
N17.8
ICD-10 Finland
Other acute renal failure
16.3
9.7
15
10
R04.2
ICD-10 Finland
Haemoptysis
9.6
9.6
19
22
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
10.4
9.5
18
19
M30.8
ICD-10 Finland
Other conditions related to polyarteritis nodosa
+∞
9.5
9
*
M30.0
ICD-10 Finland
Polyarteritis nodosa
+∞
9.5
9
*
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
+∞
9.5
9
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
5.6
9.3
27
55
205
Kela drug reimbursment
Chronic hypertension
2.9
8.9
71
338
J01MA14
ATC
moxifloxacin; systemic
4.5
8.9
32
83
B03XA01
ATC
erythropoietin; parenteral
52.8
8.8
10
*
J01MA12
ATC
levofloxacin; systemic
3.2
8.7
51
200
D64.9
ICD-10 Finland
Anaemia, unspecified
4.2
8.7
34
96
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
8.6
57
242
H26.3
ICD-10 Finland
Drug-induced cataract
94.5
8.5
9
*
V03AE02
ATC
sevelamer; oral
+∞
8.4
8
*
M31.0
ICD-10 Finland
Hypersensitivity angiitis
+∞
8.4
8
*
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
8.4
8
*
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
+∞
8.4
8
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
+∞
8.4
8
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.2
8.4
32
88
PAW37
NOMESCO Finland
Biopsy of temporal artery
47.2
7.8
9
*
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
47.2
7.8
9
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.3
7.6
28
74
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.8
7.5
56
254
1AA01
NOMESCO Finland
NA
83.6
7.5
8
*
Z49.2
ICD-10 Finland
Other dialysis
83.6
7.5
8
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
83.6
7.5
8
*
R31
ICD-10 Finland
Unspecified haematuria
4.0
7.4
30
87
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.7
7.3
32
99
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
7.3
7
*
GD1UN
NOMESCO Finland
Lung circulation SPECT
+∞
7.3
7
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
7.2
44
176
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.0
7.0
45
183
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.9
6.8
16
25
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
41.8
6.8
8
*
B05DA
ATC
Isotonic solutions
41.8
6.8
8
*
B05DB
ATC
Hypertonic solutions
41.8
6.8
8
*
C08CA13
ATC
lercanidipine; oral
3.3
6.7
36
128
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.8
6.6
44
186
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.9
6.5
26
75
GD2SN
NOMESCO Finland
Lung ventilation SPECT
72.4
6.5
7
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
+∞
6.3
6
*
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
+∞
6.3
6
*
D638, N188
ICD-10 Finland
NA
+∞
6.3
6
*
J01CA04
ATC
amoxicillin; systemic
2.8
6.3
146
1158
J47
ICD-10 Finland
Bronchiectasis
8.2
6.2
13
17
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.3
6.2
32
113
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
116
44
66.67
182.88
17.1
1.2
iu/ml
20.7
—
—
89
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
87
28
56.72
141.37
4.0
1.1
titre
254.5
—
—
11
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
65
25
39.10
98.21
12.9
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
53
13
56.27
90.31
2.1
1.1
u/ml
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
112
230
10.50
60.77
6.3
2.3
%
23.6
21.6
0.92
104
193
(3017143) Hepatitis C virus Ab [Presence] in Serum
88
148
10.26
56.08
2.5
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
46
31
19.29
53.82
6.6
7.6
iu/ml
547.8
156.6
—
11
5
(3037522) Nuclear Ab [Titer] in Serum
93
188
8.77
49.74
1.8
1.4
titre
515.9
588.9
0.16
29
47
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
88
176
8.49
47.23
2.5
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
164
619
13.47
47.14
20.2
3.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
79
150
8.33
44.15
12.6
11.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
141
485
8.51
43.21
14.5
3.3
mg/l
166.7
182.3
0.04
132
321
(3000850) Epithelial cells [#/volume] in Urine
121
362
7.51
42.81
11.5
2.7
e6/l
2.1
4.6
4.73
113
312
(3023520) Reticulocytes [#/volume] in Blood
76
144
8.15
42.38
3.9
3.0
e9/l
69.4
76.2
0.51
49
108
(42870588) Differential panel, method unspecified - Blood
149
549
9.10
42.23
17.2
5.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
81
169
7.64
41.11
13.6
4.7
mmol/l
1.3
1.9
0.70
75
135
(3012544) pH of Venous blood
82
174
7.56
40.92
14.0
4.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
46
49
12.09
40.61
1.9
1.5
iu/ml
5.6
0.1
—
6
9
(3021447) Carbon dioxide [Partial pressure] in Venous blood
81
171
7.54
40.58
13.6
4.6
kpa
5.9
5.8
0.38
81
166
(3020682) Albumin/Creatinine [Ratio] in Urine
140
519
7.55
38.19
18.2
4.2
mg/mmol
27.0
9.1
2.53
132
325
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
159
665
9.76
38.13
4.4
2.4
nmol/l
85.9
77.4
3.42
154
577
(3002582) Erythrocytes [#/volume] in Urine
139
519
7.34
37.38
16.9
3.3
e6/l
42.3
175.0
0.54
134
398
(3037121) Protein [Mass/volume] in Urine
47
59
10.27
36.70
12.1
3.8
g/l
0.6
0.1
2.05
36
23
(3001604) Monocytes [#/volume] in Blood
175
827
16.07
36.42
19.2
5.6
e9/l
0.6
0.6
0.80
167
713
(3006315) Basophils [#/volume] in Blood
175
831
15.93
36.10
19.2
5.7
e9/l
0.0
0.0
1.09
167
720
(3019198) Lymphocytes [#/volume] in Blood
175
848
15.36
34.78
19.4
5.7
e9/l
1.4
2.0
4.52
168
753
(3013115) Eosinophils [#/volume] in Blood
175
852
15.23
34.48
20.2
5.9
e9/l
0.2
0.2
2.83
169
749
(3019069) Monocytes/100 leukocytes in Blood
168
787
11.21
34.32
20.3
6.1
%
8.9
8.7
0.43
168
735
(3022096) Basophils/100 leukocytes in Blood
164
762
9.71
33.37
20.1
5.9
%
0.6
0.7
0.08
164
709
(3002030) Lymphocytes/100 leukocytes in Blood
168
803
10.83
33.05
20.1
6.0
%
21.0
27.4
12.39
168
748
(3018010) Neutrophils/100 leukocytes in Blood
167
794
10.48
33.02
18.9
5.8
%
64.9
57.5
11.66
167
745
(46235355) HIV 1 and 2 tests - Meaningful Use set
84
219
6.10
32.97
2.6
1.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
165
781
9.76
32.59
20.2
5.8
%
2.5
2.7
0.96
165
727
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
171
841
11.85
32.35
28.5
7.3
mmol/l
1.2
1.2
0.16
152
702
(3004588) Protein electrophoresis panel - Serum or Plasma
60
115
7.18
32.33
1.5
2.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
126
489
5.73
30.55
16.6
3.3
e6/l
0.2
0.6
1.98
116
363
(3028026) IgM [Mass/volume] in Serum or Plasma
56
106
7.09
30.41
2.1
1.8
g/l
0.8
1.5
1.48
50
95
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34
35
11.63
30.36
1.4
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
140
600
6.14
29.92
19.6
3.8
e6/l
20.9
58.2
2.17
135
430
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
36
42
10.35
29.41
2.0
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
121
465
5.45
29.38
15.8
3.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
120
459
5.42
29.28
6.9
4.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
38
48
9.66
29.24
1.8
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
64
144
6.21
29.07
1.7
2.5
g/l
62.1
66.7
3.08
53
131
(3026493) Urate [Moles/volume] in Serum or Plasma
115
431
5.26
28.61
5.4
3.0
umol/l
386.7
8036.1
2.17
108
357
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
35
41
10.25
28.47
2.0
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
100
337
5.18
28.35
12.9
2.7
mosm/kgh2o
501.4
546.8
1.87
94
281
(3034860) Kappa light chains.free [Mass/volume] in Serum
38
50
9.26
28.28
1.3
4.6
mg/l
79.4
188.1
0.39
30
39
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
38
50
9.26
28.28
1.3
4.6
mg/l
61.9
34.8
2.48
30
39
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
29
12.11
27.85
1.4
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
90
282
5.18
27.82
2.8
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
25
12.97
27.31
2.3
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
30
30
11.70
27.21
2.0
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
25
19
15.01
26.78
1.9
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
175
966
11.96
26.70
22.0
9.5
e9/l
4.9
4.1
4.82
168
846
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
42
67
7.77
26.52
1.1
2.3
u/l
31.8
37.4
0.89
37
60
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
34
42
9.65
26.51
1.3
1.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
53
109
6.37
26.23
12.5
4.2
mmol/l
0.7
1.9
1.66
43
85
(40760888) Immunoglobulin light chains.free panel - Serum
30
33
10.62
25.43
1.3
5.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
51
106
6.22
24.88
1.8
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
37
55
8.12
24.78
4.0
3.3
u/ml
0.4
0.4
0.12
23
31
(3009343) pH of Capillary blood
53
116
5.96
24.46
12.7
4.0
ph
7.4
7.4
—
6
13
(3044927) Protein electrophoresis panel - Urine
22
16
15.43
24.05
1.2
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
56
133
5.56
23.56
6.5
4.1
%
0.5
0.5
0.16
26
36
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
40
69
7.08
23.38
2.6
1.6
ug/l
0.8
5.4
0.58
34
61
(3020876) Protein [Mass/time] in 24 hour Urine
19
11
19.09
23.21
1.7
2.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
87
300
4.52
23.07
11.7
3.0
e6/l
0.4
1.1
2.80
71
174
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
26
27
11.01
22.86
1.7
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
27
30
10.33
22.64
1.5
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
56
138
5.35
22.51
7.3
4.2
%
0.1
0.2
0.66
29
45
(4062490)
18
10
19.79
22.37
1.3
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
99
385
4.30
22.11
2.5
2.1
mg/l
2.9
3.2
0.50
85
334
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
27
31
9.99
22.09
5.4
3.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
58
150
5.14
22.00
7.3
4.1
%
0.6
0.9
0.73
29
51
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
26
10.93
21.93
2.1
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
25
26
10.93
21.93
1.5
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
53
130
5.28
21.34
7.2
4.4
%
0.0
0.0
0.00
25
39
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
25
10.85
21.00
1.5
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
67
202
4.59
20.92
2.3
1.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
19
14
14.98
20.52
2.2
4.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
24
26
10.43
20.42
1.8
1.4
u/ml
246.2
299.1
0.16
18
14
(3022313) Gas panel - Capillary blood
43
91
5.82
20.34
12.4
4.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
177
1115
10.25
19.80
21.0
4.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
22
22
11.19
19.75
1.7
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
77
270
4.13
19.43
13.1
3.2
e6/l
1.0
2.4
1.55
61
146
(3018418) pH of Serum or Plasma
114
532
3.88
18.76
17.0
3.9
ph
7.4
7.4
0.13
27
104
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
12
15.47
18.72
1.6
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
34
62
6.47
18.67
2.4
3.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
144
794
4.42
18.36
15.7
4.8
estimate
0.0
0.0
0.00
36
167
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
64
204
4.23
18.29
2.5
1.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
143
792
4.31
17.93
11.5
3.6
estimate
0.0
0.0
0.00
34
169
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
17
13
14.27
17.91
1.1
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
171
1083
7.08
17.90
11.5
4.6
e6/l
224.8
209.8
—
5
20
(3009261) Glucose [Presence] in Urine by Test strip
144
802
4.34
17.90
11.5
3.6
estimate
0.0
0.0
0.00
36
158
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
21
23
10.15
17.65
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
42
7.33
17.15
1.7
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
14
13.24
17.14
1.1
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
28
8.76
16.51
6.5
4.1
%
64.4
57.9
1.09
22
28
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
16
11.58
15.77
1.1
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
56
180
4.00
15.57
2.3
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
40
7.05
15.44
2.5
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
21
28
8.31
15.15
6.4
3.5
e9/l
4.6
4.5
0.05
21
28
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
17
10.89
15.14
2.9
3.9
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
16
15
11.56
14.84
2.9
1.4
e6/l
471.9
532.2
—
16
10
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
13
12.45
14.60
2.1
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
24
39
6.90
14.59
1.6
1.3
u/ml
4.4
2.4
—
8
10
(3004616) Nuclear Ab [Presence] in Serum
17
19
9.73
13.99
1.4
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
29
60
5.53
13.84
3.5
2.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
86
390
3.21
13.76
3.8
2.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
35
6.98
13.61
1.3
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
35
6.98
13.61
1.3
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
10
13.89
13.50
1.8
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
10
13.89
13.50
1.8
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
17
20
9.24
13.46
2.4
1.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
22
36
6.78
13.25
1.5
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
81
362
3.17
13.18
8.6
3.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
43
130
3.99
12.85
3.0
3.1
ml/min/173m2
46.1
59.6
1.98
23
56
(3026008) Bacteria identified in Urine by Culture
102
526
3.04
12.80
4.5
3.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
12
0
+∞
12.64
1.2
0.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
47
153
3.76
12.63
6.2
9.4
mmol/l
1.3
1.4
0.22
47
148
(3023419) Bacteria identified in Sputum by Culture
18
25
7.85
12.49
2.1
3.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
75
330
3.11
12.41
2.0
1.5
g/l
2.1
2.5
0.85
56
180
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
14
10.72
12.38
1.9
1.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
85
402
3.03
12.37
2.0
1.6
nmol/l
18.7
21.4
1.03
79
327
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
101
531
2.94
12.03
2.3
2.0
u/l
158.6
165.7
0.05
95
498
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
15
10.00
11.80
1.2
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
78
4.56
11.74
1.5
1.9
g/l
8.3
7.6
0.97
22
64
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
78
4.56
11.74
1.5
1.9
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
78
4.56
11.74
1.5
1.9
g/l
4.0
3.8
0.32
21
62
(3015377) Calcium [Moles/volume] in Serum or Plasma
107
586
2.90
11.72
5.4
3.2
mmol/l
2.3
2.4
1.54
99
507
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
36
102
4.12
11.70
2.7
1.6
—
—
—
0
0
(3019225) pH of Specimen
45
151
3.60
11.49
21.1
4.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
71
4.64
11.35
1.5
2.0
g/l
3.8
3.3
1.49
21
63
(3032080) INR in Blood by Coagulation assay
117
683
2.87
11.17
7.6
7.9
inr
1.1
1.2
2.75
34
208
(44790048)
16
22
7.85
11.16
1.8
1.6
—
—
—
0
0
(44790049)
16
22
7.85
11.16
1.8
1.6
—
—
—
0
0
(44806118)
16
22
7.85
11.16
1.8
1.6
—
—
—
0
0
(44790047)
16
22
7.85
11.16
1.8
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
42
138
3.63
11.04
16.0
3.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
17
8.81
10.75
2.4
2.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
97
522
2.76
10.72
4.0
2.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
71
328
2.87
10.48
2.1
1.7
nmol/l
1123.7
1215.9
0.35
61
243
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
76
4.33
10.40
1.5
2.0
g/l
11.2
10.6
0.27
22
69
(3024928) Oxygen saturation in Venous blood
18
31
6.31
10.27
9.5
3.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
25
60
4.65
9.99
3.2
2.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
123
765
2.74
9.93
25.0
9.8
e9/l
0.0
0.0
0.09
115
632
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
73
354
2.73
9.70
2.4
1.9
mg/l
2.9
1.4
1.22
65
279
(3000494) Fungus identified in Specimen by Culture
50
200
3.04
9.47
1.8
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
59
259
2.86
9.45
2.3
2.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
36
118
3.53
9.42
1.8
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
120
752
2.63
9.30
5.3
4.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
13
7
19.81
9.07
2.7
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
109
658
2.55
9.06
2.6
2.0
pmol/l
97.6
96.2
0.10
64
317
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
23
56
4.54
9.01
3.1
1.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
141
965
2.82
9.00
10.9
5.8
mmol/l
6.9
6.7
0.36
136
898
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
25
66
4.21
8.84
1.6
2.0
g/l
31.3
37.1
2.57
19
59
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
21
49
4.70
8.65
1.4
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
13
19
7.27
8.55
1.4
3.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
71
360
2.56
8.42
17.2
5.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
81
438
2.49
8.37
12.8
6.9
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
25
69
4.02
8.33
1.6
2.3
g/l
0.1
0.5
0.98
20
61
(1616796) Gas panel - Central venous blood
17
34
5.40
8.31
9.0
2.9
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
12
7
18.17
8.19
2.1
2.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
47
197
2.84
8.09
6.2
11.4
kpa
4.9
5.2
2.01
47
190
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
14
8.28
8.07
1.2
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
28
86
3.65
8.03
6.8
2.7
%
0.7
0.7
0.04
28
86
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
28
87
3.60
7.89
6.8
2.7
%
1.1
1.1
0.07
28
87
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
56
265
2.58
7.56
1.4
1.3
iu/ml
103.0
41.5
0.86
18
87
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
0
+∞
7.33
1.1
0.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
13
8.07
7.19
1.3
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
45
199
2.66
6.91
6.5
11.3
mmol/l
0.3
1.5
1.37
39
166
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
52
247
2.52
6.91
1.4
1.3
u/ml
24.5
13.7
0.30
22
88
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
17
6.81
6.85
1.7
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
17
6.81
6.85
1.7
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
17
6.81
6.85
1.7
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
17
6.81
6.85
1.7
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
14
7.49
6.76
10.2
2.6
%
9.5
10.9
—
10
14
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
21
6.03
6.67
1.4
1.3
u/ml
53.2
1.4
—
5
5
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
36
145
2.83
6.59
10.7
4.0
mmol/l
1.2
1.2
0.15
36
128
(3042631) Mycobacterium sp identified in Specimen
13
25
5.51
6.59
3.3
3.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
18
6.43
6.50
1.7
1.4
—
—
—
0
0
(4306422)
11
18
6.43
6.50
1.4
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
18
6.43
6.50
1.7
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
18
6.43
6.50
2.3
2.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
25
82
3.36
6.47
1.2
1.3
u/ml
89.4
433.3
0.66
25
77
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
28
100
3.11
6.32
1.4
1.3
—
27.0
—
0
7
(3010421) pH of Blood
17
43
4.25
6.32
8.9
2.6
ph
7.4
7.4
0.22
17
33
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
6
0
+∞
6.28
1.5
0.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
19
6.09
6.18
2.2
1.9
—
—
—
0
0
(3017704) Immunofixation for Urine
10
8
13.11
6.15
1.1
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
26
91
3.15
6.06
1.4
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
11
20
5.78
5.88
2.0
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
20
5.78
5.88
2.3
2.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
41
4.17
5.84
1.3
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
13
28
4.91
5.83
8.8
2.3
%
76.6
59.6
2.61
13
28
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
24
5.27
5.82
1.4
1.2
u/ml
4.2
5.9
—
6
9
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
176
1478
3.77
5.70
42.2
14.8
ml/min/173m2
53.7
77.8
20.24
161
1220
(4268621)
10
17
6.16
5.69
2.0
2.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
38
4.20
5.56
1.2
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
39
179
2.49
5.48
4.5
3.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
82
514
2.05
5.39
3.8
3.3
ng/l
2342.1
1111.8
1.93
72
423
(3045414) Leukocytes [Presence] in Urine
20
64
3.38
5.37
2.3
2.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
35
4.24
5.27
1.6
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
0
+∞
5.23
1.2
0.0
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
5
0
+∞
5.23
1.8
0.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
5
0
+∞
5.23
1.2
0.0
umol/l
13.9
—
—
5
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
0
+∞
5.23
1.0
0.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
9
10.42
5.08
3.2
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
15
41
3.89
5.03
3.7
2.2
g/l
117.3
127.4
—
9
28
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
23
84
2.98
4.99
7.4
4.0
%
57.4
47.3
1.52
23
84
(3037692) Legionella sp identified in Specimen by Organism specific culture
9
10
9.38
4.84
1.1
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
13
33
4.16
4.80
4.1
2.7
%
14.5
16.1
—
8
17
(3029937) Albumin [Presence] in Urine by Test strip
71
442
1.97
4.62
13.3
3.9
estimate
0.0
0.0
0.00
35
159
(3047189) Immunofixation for 24 hour Urine
9
11
8.52
4.61
1.1
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
5
14.46
4.61
1.0
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
5
14.46
4.61
1.0
1.0
miu/ml
1725.1
1489.8
—
7
5
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
129
991
1.95
4.35
4.0
3.2
u/l
52.4
49.7
0.12
123
909
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
46
3.46
4.29
1.8
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
22
87
2.73
4.14
9.5
18.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
17
59
3.07
4.01
12.2
3.9
kpa
8.7
8.9
0.16
17
52
(3021901) Oxygen saturation in Capillary blood
12
33
3.82
3.99
4.2
2.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
38
3.60
3.98
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
24
4.34
3.94
1.2
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
15
6.24
3.86
6.8
2.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
14
44
3.36
3.86
1.6
1.5
ug/g
234.5
266.6
—
6
24
(3017732) Neutrophils [#/volume] in Blood
24
103
2.52
3.85
2.2
2.9
e9/l
5.0
3.6
1.42
15
78
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
89
624
1.81
3.85
6.2
4.0
ng/l
46.7
35.3
0.71
78
445
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
5
12.33
3.79
1.0
1.0
%
101.8
104.0
—
6
5
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
5
12.33
3.79
1.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
12
6.90
3.71
1.3
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
12
6.90
3.71
1.3
2.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
118
906
1.81
3.71
3.4
2.7
—
—
—
0
0
(3012565) Volume of 24 hour Urine
7
9
8.02
3.59
1.7
3.3
ml
2110.0
2160.6
—
7
9
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
26
4.01
3.57
1.2
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
93
672
1.76
3.55
2.3
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
7
8.80
3.28
1.8
2.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
7
8.80
3.28
1.8
2.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
7
8.80
3.28
1.8
2.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
7
8.80
3.28
1.8
2.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
19
4.92
3.28
2.0
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
9
19
4.92
3.28
1.9
1.9
%
86.1
90.7
—
9
19
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
38
3.30
3.27
1.3
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
54
340
1.82
3.24
1.9
1.7
pmol/l
445.0
454.3
0.09
46
280
(3035947) Staphylolysin Ab [Units/volume] in Serum
7
11
6.56
3.21
1.4
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
85
614
1.70
3.15
13.9
3.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
66
445
1.74
3.13
13.8
3.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
169
1489
2.28
3.13
6.0
4.2
mmol/l
1.3
1.3
0.94
162
1336
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
174
1552
2.53
3.13
6.6
4.8
mmol/l
4.4
4.6
2.20
169
1413
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
45
3.03
3.09
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
9
21
4.44
3.03
1.2
1.8
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
5
10.22
2.99
1.2
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
5
10.22
2.99
1.0
3.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
5
10.22
2.99
1.2
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
51
323
1.79
2.98
3.5
3.9
ng/l
199.5
166.1
0.13
45
259
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
13
5.54
2.89
6.7
4.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
42
2.98
2.80
1.1
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
6
8.51
2.76
2.0
3.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
6
8.51
2.76
1.2
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
6
8.51
2.76
2.0
3.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
6
8.51
2.76
2.0
3.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
6
8.51
2.76
1.2
1.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
14
5.15
2.75
1.3
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
19
4.35
2.71
1.3
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
14
55
2.67
2.68
1.5
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
23
115
2.14
2.64
6.1
8.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
15
4.80
2.62
1.6
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
142
1206
1.71
2.61
4.6
4.0
pmol/l
15.5
14.8
2.42
137
1070
(3034426) Prothrombin time (PT)
5
7
7.30
2.56
1.2
1.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
5
7
7.30
2.56
9.2
5.6
%
67.0
46.9
—
5
7
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
7
7.30
2.56
1.4
1.3
iu/ml
203.8
106.3
—
5
7
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
16
4.50
2.50
1.9
2.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
16
4.50
2.50
1.3
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
16
4.50
2.50
1.9
2.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
16
4.50
2.50
1.9
2.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
24
125
2.05
2.49
1.4
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
53
356
1.68
2.48
1.5
1.3
u/ml
0.5
1.7
1.13
15
87
(3048689) Calprotectin [Mass/mass] in Stool
31
178
1.89
2.45
1.9
2.2
ug/g
147.8
141.7
0.05
26
140
(4035726)
28
158
1.91
2.33
1.1
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
13
4.73
2.29
1.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
18
4.00
2.27
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
9
5.67
2.22
1.4
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
24
3.43
2.20
1.6
1.7
pg
32.5
32.5
—
8
24
(40761511) CBC panel - Blood by Automated count
178
1645
2.41
2.20
42.5
14.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
22
117
2.00
2.17
5.9
2.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
27
156
1.85
2.10
23.7
3.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
10
5.10
2.08
1.2
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
21
3.42
1.98
1.1
1.5
ug/l
27.0
16.1
—
7
21
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
27
3.05
1.96
7.3
3.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
5
11
4.64
1.95
1.8
2.5
mu/l
15.2
16.2
—
5
11
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
11
4.64
1.95
1.4
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
11
4.64
1.95
1.0
1.0
—
—
—
0
0
(3020891) Body temperature
14
65
2.25
1.93
4.3
4.2
—
—
—
0
0
(4094501)
9
35
2.65
1.82
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
88
2.02
1.81
2.4
2.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
58
429
1.51
1.76
1.6
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
18
3.41
1.76
1.5
1.3
—
—
—
0
0
(3013512) EKG study
66
503
1.48
1.73
5.7
4.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
18
98
1.92
1.68
1.7
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
19
3.23
1.67
1.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
19
3.23
1.67
1.0
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
19
3.23
1.67
1.7
1.5
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
19
3.23
1.67
1.0
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
19
3.23
1.67
1.0
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
19
3.23
1.67
1.0
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
19
3.23
1.67
1.0
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
11
49
2.32
1.67
1.6
3.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
14
3.64
1.62
1.6
2.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
14
3.64
1.62
1.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
14
3.64
1.62
1.6
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
14
3.64
1.62
1.6
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
148
1329
1.52
1.58
55.5
19.3
%
14.2
13.8
3.46
148
1313
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
160
1463
1.61
1.56
5.9
4.8
mu/l
2.0
2.0
0.02
155
1308
(3045788) Cell count panel - Pleural fluid
5
15
3.39
1.53
2.2
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
39
2.37
1.45
1.9
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
120
1.75
1.41
1.4
1.5
—
—
—
0
0
(4010399)
21
128
1.72
1.40
1.2
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
17
2.99
1.36
1.0
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
44
324
1.47
1.35
11.3
4.1
kg/l
1.0
1.0
—
7
46
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
63
497
1.40
1.34
4.3
5.1
ug/l
2.8
2.7
0.04
53
439
(3000492) Spirometry study
23
147
1.64
1.30
1.8
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
18
2.82
1.29
1.0
1.8
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
8
36
2.28
1.26
2.0
1.1
mmol/l
3.4
4.1
—
8
31
(3019832) Treponema pallidum Ab [Presence] in Serum
15
87
1.79
1.19
2.1
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
20
2.54
1.16
1.6
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
16
96
1.73
1.14
13.4
3.5
—
—
—
0
0
(3044889) 12 lead EKG panel
125
1123
1.33
1.07
4.6
4.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
48
1.92
1.02
1.7
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
23
2.20
0.98
1.4
1.6
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
31
0.00
0.97
0.0
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
0
31
0.00
0.97
0.0
1.2
—
0.5
—
0
26
(3014051) Protein [Presence] in Urine by Test strip
8
42
1.94
0.90
2.6
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
33
252
1.38
0.84
1.8
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
8
47
1.73
0.82
11.0
16.2
mmol/l
1.1
1.1
—
8
40
(3009542) Hematocrit [Volume Fraction] of Blood
151
1416
1.33
0.81
47.4
17.0
%
36.3
39.7
5.68
108
975
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
27
0.00
0.78
0.0
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
38
1.87
0.74
8.7
1.2
nmol/l
0.9
0.8
—
7
30
(40768443) Skin Pathology biopsy report
12
76
1.62
0.73
1.0
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
26
1.95
0.71
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
197
1.37
0.70
15.2
8.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
26
200
1.35
0.65
1.9
4.8
ug/l
2.2
27.4
0.64
19
168
(3008898) HLA-B27 [Presence]
8
49
1.66
0.63
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
52
1.56
0.60
8.3
4.6
—
—
—
0
0
(4281824)
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
90
0.54
0.57
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
65
1.57
0.56
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
37
1.64
0.56
1.2
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
10
66
1.54
0.53
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
66
1.54
0.53
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
46
401
1.19
0.44
3.0
4.5
%
26.7
20.9
1.42
27
201
(1617658) Protocol used for examination of sentinel lymph nodes
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
16
0.00
0.41
0.0
2.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
34
1.48
0.40
2.8
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
34
1.48
0.40
1.0
1.1
u/l
21.5
21.7
—
5
27
(3028707) Methadone [Presence] in Urine by Screen method
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.2
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
19
155
1.25
0.34
1.3
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
86
0.69
0.34
1.5
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
159
1544
1.19
0.33
7.8
4.8
mmol/l
5.8
6.0
1.43
148
1397
(40768797) Stomach Pathology biopsy report
27
232
1.19
0.31
1.2
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
108
0.73
0.30
1.3
1.7
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
8
63
1.28
0.28
1.3
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
48
525
0.89
0.27
4.6
3.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
23
202
1.16
0.21
1.2
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
12
0.00
0.21
0.0
2.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
5
43
1.17
0.21
13.0
3.8
mmol/l
7.2
7.4
—
5
43
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
5
45
1.11
0.10
13.0
3.7
mmol/l
1.3
1.4
—
5
45
(40768793) Breast Pathology biopsy report
5
48
1.04
0.09
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
88
1.14
0.08
1.2
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
108
1.12
0.07
2.3
1.9
—
—
—
0
0
(3002256) Pathology report gross observation
21
196
1.08
0.07
1.6
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
11
102
1.08
0.03
1.6
1.3
iu/ml
191.7
174.6
—
5
41
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
15
146
1.03
0.00
4.1
3.3
ng/l
561.7
183.2
0.63
15
132
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
23
228
1.01
0.00
1.5
1.4
—
—
—
0
0
(1002224) Polysomnography panel
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
16.0
—
948.3
—
0
9
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
100
1.00
0.00
2.4
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.7
—
0.6
—
0
7
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
55.7
—
0
7
(21494755) Public health laboratory ask at order entry panel
9
96
0.93
0.00
1.1
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
8
0.00
0.00
0.0
2.4
—
13.7
—
0
8
(4198724)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
18.8
—
1566.0
—
0
9
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
5
0.00
-0.00
0.0
3.6
—
0.1
—
0
5
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
-0.00
0.0
4.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_MICROPOLYANG and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_MICROPOLYANG | 2.749 [1.87, 4.04] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.51 |
During the follow-up period (1.1.1998 — 31.12.2019), 83 out of 398 females with M13_MICROPOLYANG died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_MICROPOLYANG | 2.227 [1.42, 3.48] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.08 |
During the follow-up period (1.1.1998 — 31.12.2019), 83 out of 278 males with M13_MICROPOLYANG died.
Mortality risk
Mortality risk for people of age
years, who have M13_MICROPOLYANG.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.3% | 0.427% |
| 5 | 1.814% | 2.869% |
| 10 | 4.159% | 6.919% |
| 15 | 8.407% | 12.425% |
| 20 | 14.379% | 21.206% |
Relationships between endpoints
↥Index endpoint: M13_MICROPOLYANG – Microscopic polyangiitis
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data